Profile
Michael Cato's current job is as Vice President-Quality Assurance at Cato Research LLC since 2005.
His former jobs include being an Associate at Cato BioVentures and serving as President at Hemodynamic Therapeutics, Inc. from 2000 to 2012.
He obtained a graduate degree from North Carolina State University.
Michael Cato active positions
| Companies | Position | Start |
|---|---|---|
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Corporate Officer/Principal | 31/05/2005 |
Former positions of Michael Cato
| Companies | Position | End |
|---|---|---|
Hemodynamic Therapeutics, Inc.
Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Developes a novel small molecule combination therapy for obesity-related hypertension | President | - |
Cato BioVentures
Cato BioVentures Investment ManagersFinance Cato BioVentures invests in both private and public companies located in United States. The firm targets companies operating in the fields of innovative therapeutics, medical devices and stem cell technologies. It provides financing for seed, early and later stage capital requirements. It also makes co-investments. | Private Equity Analyst | - |
Training of Michael Cato
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Commercial Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cato BioVentures
Cato BioVentures Investment ManagersFinance Cato BioVentures invests in both private and public companies located in United States. The firm targets companies operating in the fields of innovative therapeutics, medical devices and stem cell technologies. It provides financing for seed, early and later stage capital requirements. It also makes co-investments. | Finance |
Hemodynamic Therapeutics, Inc.
Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Developes a novel small molecule combination therapy for obesity-related hypertension | Health Technology |
- Stock Market
- Insiders
- Michael Cato
















